Published on 27 Apr 2024 on Simply Wall St. via Yahoo Finance
Merck & Co., Inc. (NYSE:MRK) just released its quarterly report and things are looking bullish. The company beat expectations with revenues of US$16b arriving 3.8% ahead of forecasts. Statutory earnings per share (EPS) were US$1.87, 4.4% ahead of estimates. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
View our latest analysis for Merck
earnings-and-revenue-growth